"Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life Setting"
Read more here: shorturl.at/qEkep
#maribavir #CMV #cytomegalovirus #infection #transplant
@esottransplant.bsky.social
The third slide from the November 2025 issue of Journal Watch, titled "Maribavir for refractory cytomegalovirus (CMV) infection (with or without resistance) in solid organ transplant recipients: Subgroup analysis of the phase 3 randomized SOLSTICE study" For a more screenreader friendly version, the full issue PDF is at https://www.ishlt.org/docs/default-source/journal-watch/202511_journalwatch_id_nov2025.pdf.
Closing out November's #ISHLTJournalWatch, @sarawinndong.febrilepodcast.com reviews a study from @jhlt.bsky.social on the use of #Maribavir for #CMV infection in SOT recipients—an important addition to the toolbox in treating this infection in #transplant recipients.
#TransplantSky #IDSky #MedSky
#Maribavir offers better #cytomegalovirus infections control and fewer toxicities than standard antivirals, but resistance can still emerge, demanding close monitoring.
🆓https://doi.org/10.53855/bjt.v28i1.711_ENG
@scielo.org #BJT #transplant